US Wound Registry data confirm outcome of African Americans with lower extremity wounds is worse than in whites, particularly true for DFU outcomes where amputation rates are higher. USWR data confirm use of advanced therapeutics in wound care is determined by payer. Whether a Medicare beneficiary has a secondary insurance determines if they get a cellular product, & use of all advanced therapeutics has changed with rise of Medicare advantage plans. We do not know if this has changed outcome.
Idea No. 661